drugset / Trial / NCT02273427

Effect of Different Food Compositions on Bioavailability of BIIL 284 BS in Healthy Male Volunteers

NCT02273427

Phase 1 Completed 24 enrolled Boehringer Ingelheim
RandomizedCrossoverOpen-labelTreatment

Summary

food effect, relative bioavailability, pharmacokinetics, safety and tolerability

Timeline

Start
2000-02
Primary completion
2000-03
Completion

Drugs

EvaluationDrugModalityDoseRoute
Subject AMELUBANT Small molecule 75 mg

Indications

No indication recorded.